Assessing the Impact of Malaria on Children Aged 5–10 in the Sahel: Is There a Need to Modify Seasonal Chemoprophylaxis Strategies? - Scorecard - MDSpire

Assessing the Impact of Malaria on Children Aged 5–10 in the Sahel: Is There a Need to Modify Seasonal Chemoprophylaxis Strategies?

  • By

  • Médard Djedanem

  • Mamane Aminou Yacoudima Yacoubou

  • Abdoussalam Zakari

  • Idi Issa

  • Mahamadou Yahaya

  • Mamane Zaneidou

  • Issaka Mody

  • Daniel Bikele Onana

  • Jean Testa

  • Ronan Jambou

  • January 30, 2026

  • 0 min

Share

Clinical Scorecard: Assessing the Impact of Malaria on Children Aged 5–10 in the Sahel: Is There a Need to Modify Seasonal Chemoprophylaxis Strategies?

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationChildren aged 5-10 in the Sahel region, particularly in Niger.
Care Setting

Key Highlights

  • source

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider inclusion of children aged 5-10 in SMC strategies, with specific dosing and frequency.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Expand on the rationale for including older children in SMC strategies.

        Clinical Best Practices

        • best_practices

        References

        Original Source(s)

        Assessing the Impact of Malaria on Children Aged 5–10 in the Sahel: Is There a Need to Modify Seasonal Chemoprophylaxis Strategies?

        • by Médard Djedanem, Mamane Aminou Yacoudima Yacoubou, Abdoussalam Zakari, Idi Issa, Mahamadou Yahaya, Mamane Zaneidou, Issaka Mody, Daniel Bikele Onana, Jean Testa, Ronan Jambou

        • January 30, 2026

        Related Content

        Clinical characteristics and long-term prognosis of talaromycosis in children with novel and reported inborn errors of immunity

        HPV vaccine hesitancy among Chinese adults and its influencing factors in the context of improved vaccine accessibility

        Estimated pneumococcal disease burden in children due to serotypes covered by different pneumococcal conjugate vaccines in five Latin American countries